论文部分内容阅读
根据４０２例乳腺癌术后复发患者的临床回顾性分析的资料，探讨影响乳腺癌术后复发转移的预后因素及其改善疗效的途径。分析结果表明，６０％的乳腺癌复发患者在复发后２年内死亡。乳腺癌复发患者复发后的２年生存率与患者的年龄、月经状况、雌激素受体与孕酮受体状况、手术方式、预防或治疗性去势无关，与首发部位、原发肿瘤分期、肿瘤大小、手术时淋巴结转移数、复发后治疗情况及无复发间期长短有关。文章指出重视手术操作，合理安排术后治疗及加强术后患者的随诊，力求改善疗效。
According to the clinical retrospective analysis of 402 cases of postoperative recurrence of breast cancer, the prognostic factors affecting the recurrence and metastasis of breast cancer and the ways to improve the curative effect were explored. The analysis showed that 60% of breast cancer recurrence patients died within 2 years after relapse. The 2-year survival rate after relapse in patients with breast cancer recurrence was not related to the patient’s age, menstrual status, estrogen receptor and progesterone receptor status, surgical approach, prophylactic or therapeutic occlusion, and the first site, primary tumor stage, The size of the tumor, the number of lymph node metastases during surgery, the treatment after recurrence, and the length of the recurrence-free interval were related. The article pointed out that the importance of surgical operations, reasonable arrangements for postoperative treatment and strengthen the follow-up of patients after surgery, and strive to improve efficacy.